Anemia Evaluation Guidelines

Initial Assessment

The National Comprehensive Cancer Network recommends assessing duration and onset of symptoms, including fatigue, syncope, and exercise dyspnea, in patients with anemia 1, 2
A detailed medication history, including exposure to chemotherapeutic agents, anticoagulants, and NSAIDs, is crucial in evaluating anemia 3, 4
Comorbidities, such as renal insufficiency, chronic inflammation, and malignancy, should be considered as potential contributing factors to anemia 1, 2
Family history of inherited anemias, such as thalassemia and sickle cell disease, should be assessed 5
Dietary history should be evaluated to assess for nutritional deficiencies 6

A complete blood count (CBC) with indices is recommended to characterize anemia and identify other cytopenias 6, 5
Peripheral blood smear review is necessary to assess red blood cell morphology 3, 4
Reticulocyte count should be performed to distinguish between production and destruction/loss problems 6, 5
Morphologic classification based on mean corpuscular volume (MCV) can help identify underlying causes of anemia, including iron deficiency, thalassemia, and anemia of chronic disease 6

The National Comprehensive Cancer Network recommends assessing chemotherapy regimen and cycle number, as anemia rates increase with additional cycles 1, 2
Evaluation of nadir hemoglobin level and time to nadir is crucial in patients with cancer-related anemia 1, 2
Anemia of chronic disease/inflammation related to cancer should be considered in patients with cancer 1, 2
Bone marrow infiltration by cancer should be evaluated in patients with anemia and cancer 6, 5

Reticulocyte index (RI) assessment can help identify underlying causes of anemia, including decreased RBC production and blood loss or hemolysis 6, 5

Failing to consider multiple causes of anemia in cancer patients can lead to inadequate management 3, 1
Overlooking functional iron deficiency in the setting of inflammation can result in delayed diagnosis and treatment 6, 5
Misinterpreting ferritin levels can lead to incorrect diagnosis and treatment of iron deficiency anemia 6, 5
Neglecting to perform Coombs testing in patients with chronic lymphocytic leukemia, non-Hodgkin's lymphoma, or history of autoimmune disease can result in delayed diagnosis and treatment of hemolytic anemia 3, 8